BioExx Specialty Proteins Ltd.

BioExx Specialty Proteins Ltd.

February 05, 2010 10:15 ET

BioExx Named to 2010 TSX Venture 50

Ranked #1 in Clean Technology Sector

TORONTO, ONTARIO--(Marketwire - Feb. 5, 2010) - BioExx Specialty Proteins Ltd. (TSX:BXI) ("BioExx" or "the Company") is pleased to announce that the TSX Venture Exchange has today announced that BioExx has been named as one of the TSX Venture 50 for 2010. The TSX Venture 50 is a composition of some of the strongest performers listed on TSX Venture Exchange, and is comprised of 10 emerging companies in five industry sectors that have been identified as leaders in Canada's public venture market.

The 2010 TSX Venture 50 are selected based on four equally weighted criteria that include return on investment, trading, analyst coverage and market capitalization growth, in the Clean Technology, Diversified Industries, Mining, Oil & Gas, and Technology and Life Sciences sectors.

"We are honoured to be named as part of this year's TSX Venture 50," said BioExx CEO, Chris Carl. "We believe that being selected as a part of this high-achieving group of companies is a reflection of the very hard work put forth by the entire BioExx team to bring to full commercialization our Specialty Protein technology. We are especially proud of our leadership ranking in the Clean Technology sector as we have consistently strived to achieve a unique combination of best-of-breed economics and sustainability. The access to capital provided by our listing on TSX Venture Exchange has allowed us to achieve the results we have to date, including our recent graduation to the Toronto Stock Exchange."

"We are pleased to celebrate the 2010 TSX Venture 50," said John McCoach, President, TSX Venture Exchange. "These outstanding companies are proven leaders in their respective sectors and we are proud to have them listed on TSX Venture Exchange. We wish them all continued success."

About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets.

BioExx uses patented technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent- pending methods for separating proteins from oilseeds. Without the extraction of virtually all of the oil at low temperatures, and in the manner developed by BioExx, the protein separation methods would not work. It is the combination of these proprietary processes that has enabled BioExx to develop product profiles that do not infringe either on methods or product profiles developed by others. Through its extensive research and development work, together with an exhaustive review of published and prior art, BioExx is confident that all of its processes and resulting products are unique in the marketplace.

Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint.

BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis. To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit

The information contained herein is for information purposes only and is not an invitation to purchase securities listed on TSX Venture Exchange and/or Toronto Stock Exchange. TMX Group Inc. and its affiliates do not endorse or recommend any securities referenced. Neither TMX Group Inc. nor its affiliated companies represents, warrants or guarantees the accuracy or the completeness of the information. You should not rely on the information contained herein for any trading, business or financial purposes. TMX Group Inc. and its affiliates assume no liability for any errors or inaccuracies herein or any use or reliance upon this information.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • BioExx Specialty Proteins Ltd.
    Chris Schnarr
    Chief Financial Officer
    (416) 588-4442 x111
    Investor Relations:
    Brisco Capital Partners
    Scott Koyich, President
    (403) 262-9888